Dipeptidyl peptidase IV in the hypothalamus and hippocampus of monosodium glutamate obese and food-deprived rats

Metabolism: Clinical and Experimental

Volumn 60, Issue 2, 2011, Pages 234-242

  Alponti, Rafaela Fadoni ^a,b   Frezzatti, Rodrigo ^a   Barone, Juliana Marton ^a   Alegre, Valter De Sousa ^a   Silveira, Paulo Flavio ^a  

^a INSTITUTO BUTANTAN   (Brazil)

^b UNIVERSITY OF SÃO PAULO   (Brazil)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ENDORPHIN; DIPEPTIDYL PEPTIDASE IV; DIPROTIN A; GLUTAMATE SODIUM; GLYCERALDEHYDE 3 PHOSPHATE DEHYDROGENASE; NEUROPEPTIDE Y;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARCUATE NUCLEUS; ARTICLE; BRAIN REGION; CENTRAL NERVOUS SYSTEM; CONTROLLED STUDY; ENERGY BALANCE; ENZYME ACTIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FLUOROMETRY; FOOD DEPRIVATION; HIPPOCAMPUS; HYDROLYSIS; HYPOTHALAMUS; MALE; NONHUMAN; NUCLEOTIDE SEQUENCE; OBESITY; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FAMILY; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION;

ANIMALS; ANIMALS, NEWBORN; DIPEPTIDYL PEPTIDASE 4; DISEASE MODELS, ANIMAL; FASTING; FOOD DEPRIVATION; HIPPOCAMPUS; HYPOTHALAMUS; MALE; OBESITY; RATS; SODIUM GLUTAMATE;

EID: 78751648843     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2009.12.031     Document Type: Article

References (55)

1. Zammaretti F., Panzica G., and Eva C. Fasting, leptin treatment and glucose administration differentially regulate Y(1) receptor gene expression in the hypothalamus of transgenic mice Endocrinology 142 2001 3774 3782
2. Chelikani P.K., Ambrose J.D., and Keisler D.H. Effect of short-fasting on plasma concentrations of leptin and other hormones and metabolites in dairy cattle Domest Anim Endocrinol 26 2004 33 48
3. Crane C., Akhter N., and Johnson B.W. Fasting and glucose effects on pituitary leptin expression: is leptin a local signal for nutrient status? J Histochem Cytochem 55 2007 1059 1073
4. Bernardis L.L., and Patterson B.D. Correlation between "Lee index" and carcass fat content in weanling and adult female rats with hypothalamic lesions J Endocrinol 40 1968 527 528
5. Leigh F.S., Kaufman L.N., and Young J.B. Diminished epinephrine excretion in genetically obese (ob/ob) mice and monosodium glutamate-treated rats Int J Obes Relat Metab Dis 16 1992 597 604
6. Nakagawa T., Ukai K., and Ohyama T. Effects of chronic administration of sibutramine on body weight, food intake and motor activity in neonatally monosodium glutamate-treated obese female rats: relationship of antiobesity effect with monoamines Exp Anim 49 2000 239 249
7. Dolnikoff M., Martin-Hidalgo A., and Machado U.F. Decreased lipolysis and enhanced glycerol and glucose utilization by adipose tissue prior to development of obesity in monosodium glutamate (MSG) treated-rats Int J Obes Relat Metab Dis 25 2001 426 433
8. Pethiyagoda C.L., Welch D.R., and Fleming T.P. Dipeptidyl peptidase IV (DPPIV) inhibits cellular invasion of melanoma cells Clin Exp Metastasis 18 2000 391 400
9. Gorrell M.D., Gysbers V., and McCaughan G.W. CD26: a multifunctional integral membrane and secreted protein of activated lymphocytes Scand J Immunol 54 2001 249 264
10. Gorrell M.D. Dipeptidyl peptidase IV and related enzymes in cell biology and liver disorders Clin Sci 108 2005 277 292
11. Boonacker E., and Van Noorden C.J. The multifunctional or moonlighting protein CD26/DPPIV Eur J Cell Biol 82 2003 53 73
12. Sharoyan S.G., Antonyan A.A., and Mardanyan S.S. Complex of dipeptidyl peptidase II with adenosine deaminase Biochemistry (Mosc) 73 2008 943 949
13. Hildebrandt M., Reutter W., and Arck P. A guardian angel: the involvement of dipeptidyl peptidase IV in psychoneuroendocrine function, nutrition and immune defence Clin Sci 99 2000 93 104
14. Ranganath L.R. Incretins: pathophysiological and therapeutic implications of glucose-dependent insulinotropic polypeptide and glucagon-like peptide-1 J Clin Pathol 61 2008 401 409
15. Maes M.B., Dubois V., and Brandt I. Dipeptidyl peptidase 8/9-like activity in human leukocytes J Leukoc Biol 81 2007 1252 1257
16. Zambotti-Villela L., Yamasaki S.C., and Villarroel J.S. Prolyl, cystyl and pyroglutamyl peptidase activities in the hippocampus and hypothalamus of streptozotocin-induced diabetic rats Peptides 28 2007 1586 1595 (Pubitemid 47247968)
17. Zambotti-Villela L., Yamasaki S.C., and Villarroel J.S. Prospective evaluation of aminopeptidase activities in plasma and peripheral organs of streptozotocin-induced diabetic rats J Endocrinol Invest 31 2008 492 498
18. Olivo R do A., Teixeira C de F., and Silveira P.F. Representative aminopeptidases and prolyl endopeptidase from murine macrophages: comparative activity levels in resident and elicited cells Biochem Pharmacol 69 2005 1441 1450
19. Kaufhold A., Nigam P.K., and Dhir R.N. Prevention of latently expressed CYP2C11, CYP3A2, and growth hormone defects in neonatally monosodium glutamate-treated male rats by the n-methyl-d-aspartate receptor antagonist dizocilpine maleate JPET 302 2002 490 496
20. Rogers P., and Webb G.P. Estimation of body fat in normal and obese mice Br J Nutr 43 1980 83 86
21. Paxinos G., and Watson C. The rat brain in stereotaxic coordinates 6th ed 2007 Academic Press Amsterdam
22. Bergmeyer H.U., and Brent E. Assay with pyruvate and NADH 2nd ed Methods in enzymatic analysis 1972 Academic Press Inc. London 574 577
23. Bradford M.M. A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding Anal Biochem 72 1976 248 254
24. Silveira P.F., Gil J., and Casis L. Peptide metabolism and the control of body fluid homeostasis Curr Med Chem Cardiovasc Hematol Agents 2 2004 219 238
25. 2-adrenoceptor gene expression in hippocampus Neurosci Lett 412 2007 163 167
26. Hosokawa R., Ohashi-Takeuchi H., and Yamada N. Lactate dehydrogenase isoenzymes in matrix vesicles (review) Bone Miner 17 1992 177 181
27. Noraberg J., Jensen C.V., and Bonde C. The developmental expression of fluorescent proteins in organotypic hippocampal slice cultures from transgenic mice and its use in the determination of excitotoxic neurodegeneration Altern Lab Anim 35 2007 61 70
28. Gillespie L., Konings P.N., and Merril B.J. A specific enzyme assay for aminopeptidase M in rat brain Life Sci 51 1992 2091 2106
29. Irazusta J., Larrinaga G., and Agirregoitia N. Effects of morphine administration and its withdrawal on rat brain aminopeptidase activities Regul Pept 110 2003 225 230
30. Larrinaga G., Gil J., and Meana J.J. Aminopeptidase activity in the postmortem brain of human heroin addicts Neurochem Int 46 2005 213 219
31. Erbeznik H., and Hersh L.B. A novel mammalian high-molecular-weight aminopeptidase Arch Biochem Biophys 344 1997 228 234
32. Thompson M.W., Tobler A., Fontana A., and Hersh L.B. Cloning and analysis of the gene for the human puromycin-sensitive aminopeptidase Biochem Biophys Res Commun 258 1999 234 240
33. Alponti RF, Silveira PF. Neutral aminopeptidase and dipeptidyl deptidase IV activities in plasma of monosodium glutamate obese and food-deprived rats. Obesity in press; doi:10.1038/oby.2009.378.
34. Qi S.Y., Riviere P.J., and Trojnar J. Cloning and characterization of dipeptidyl peptidase 10, a new member of an emerging subgroup of serine proteases Biochem J 373 2003 179 189
35. Frerker N., Wagner L., and Wolf R. Neuropeptide Y (NPY) cleaving enzymes: structural and functional homologues of dipeptidyl peptidase 4 Peptides 28 2007 257 268
36. Mentlein R. Cell-surface peptidases Int Rev Cytol 235 2004 165 213
37. Pacheco R., Martinez-Navio J.M., and Lejeune M. CD26, adenosine deaminase, and adenosine receptors mediate costimulatory signals in the immunological synapse Proc Natl Acad Sci USA 102 2005 9583 9588
38. Havre P.A., Abe M., and Urasaki Y. The role of CD26/dipeptidyl peptidase IV in cancer Front Biosci 13 2008 1634 1645
39. Bjelke J.R., Christensen J., and Nielsen P.F. Dipeptidyl peptidases 8 and 9: specificity and molecular characterization compared with dipeptidyl peptidase IV Biochem J 396 2006 391 399
40. Dhillo W.S., and Bloom S.R. Hypothalamic peptides as drugs targets for obesity Curr Opin Pharmacol 1 2001 651 655
41. Volkoff H., Canosa L.F., and Unniappan S. Neuropeptides and the control of food intake in fish Gen Comp Endocrinol 142 2005 3 19
42. Arora S., and Anubhuti Role of neuropeptides in appetite regulation and obesity-a review Neuropeptides 40 2006 375 401
43. Schwartz M.W., and Porte D. Diabetes, obesity, and the brain Science 307 2005 375 379
44. Mentlein R. Dipeptidyl-peptidase IV (CD26)-role in the inactivation of regulatory 3 peptides Regul Pept 85 1999 9 24
45. Berglund M.M., Hipskind P.A., and Gelert D.R. Recent developments in our understanding of the physiological role of PP-fold peptide receptor subtypes Exp Biol Med 228 2003 217 244
46. Kamiji M.M., and Inui A. NPY Y2 and Y4 receptors selective ligands: promising anti-obesity drugs? Curr Top Med Chem 7 2007 1734 1742
47. Davidson T.L., Kanoski S.E., and Schier L.A. A potential role for the hippocampus in energy intake and body weight regulation Curr Opin Pharmacol 7 2007 613 616
48. Xapelli S., Agasse F., and Ferreira R. Neuropeptide Y as an endogenous antiepileptic, neuroprotective and pro-neurogenic peptide Recent Patents CNS Drug Discov 1 2006 315 324
49. Simmons M.L., and Chavkin C. Endogenous opioid regulation of hippocampal function Int Rev Neurobiol 39 1996 145 196
50. Eva C., Serra M., and Mele P. Physiology and gene regulation of the brain NPY Y1 receptor Front Neuroendocrinol 27 2006 308 339
51. Sajdyk T.J., Shekhar A., and Gehlert D.R. Interaction between NPY and CRF in the amygdale to regulate emotionality Neuropeptides 38 2004 225 234
52. Carvajal C., Dumont Y., and Quirion R. Neuropeptide Y: role in emotion and alcohol dependence CNS Neurol Disord Drug Targets 5 2006 181 195
53. Scott K.M., Bruffaerts R., and Simon G.E. Obesity and mental disorders in adult general population: results from the world mental health surveys Int J Obes 32 2008 192 200
54. Scott K.M., McGee M.A., and Wells E. Obesity and mental disorders in adult general population J Pshyc Res 64 2008 94 105
55. Danilova O.V., Tai A.K., and Mele D.A. Neurogenin 3-specific dipeptidyl peptidase-2 deficiency causes impaired glucose tolerance, insulin resistance, and visceral obesity Endocrinology 150 2009 5240 5248